, Tracking Stock Market Picks
Enter Symbol:

Sell BTX
up 215.01 %

BIOTIME INC (BTX) rated Sell with price target $2 by BioLogic Equity Research

Posted on: Thursday,  Jan 6, 2011  8:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell BIOTIME INC (AMEX: BTX) on 01/06/2011, when the stock price was $8.60. Since
then, BIOTIME INC has lost 68.26% as of 08/24/2015's recent price of $2.73.
If you would have followed this BioLogic Equity Research's recommendation on BTX, you would have gained 215.01% of your investment in 1691 days.

BioTime, Inc. is a biomedical organization engaged in the development of synthetic plasma expanders and blood volume substitute solutions for use in surgery, trauma care, organ transplant procedures, and other areas of medicine. The Company?s operating revenues have been generated primarily from licensing fees related to the sale of its plasma volume expander products, primarily Hextend. The company began to make its first stem cell research products available during the year ended December 31, 2008, but it had not yet generated significant revenues in that business segment.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2011 8:25 AM Sell
8.60 2.00
as of 12/30/2011
1 Week down  -3.56 %
1 Month down  -29.97 %
3 Months down  -31.74 %
1 YTD up  32.44 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy